The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository

Objective Although systemic lupus erythematosus (SLE) is the most common autoimmune disease associated with antiphospholipid antibodies (aPL), limited data exist regarding the impact of SLE on the clinical phenotype of aPL‐positive patients. The primary objective of this study was to compare the cli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis care & research (2010) 2019-01, Vol.71 (1), p.134-141
Hauptverfasser:	Unlu, Ozan, Erkan, Doruk, Barbhaiya, Medha, Andrade, Danieli, Nascimento, Iana, Rosa, Renata, Banzato, Alessandra, Pengo, Vittorio, Ugarte, Amaia, Gerosa, Maria, Ji, Lanlan, Efthymiou, Maria, Branch, D. Ware, Jesus, Guilherme Ramires, Tincani, Angela, Belmont, H. Michael, Fortin, Paul R., Petri, Michelle, Rodriguez, Esther, Pons‐Estel, Guillermo J., Knight, Jason S., Atsumi, Tatsuya, Willis, Rohan, Zuily, Stephane, Tektonidou, Maria G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anemia Antibodies, Antiphospholipid - blood Antiphospholipid antibodies Antiphospholipid syndrome Antiphospholipid Syndrome - blood Antiphospholipid Syndrome - diagnosis Antiphospholipid Syndrome - epidemiology Autoimmune diseases Cardiovascular diseases Classification Clinical trials Cognitive ability Databases, Factual Female Glycoprotein I Hemolytic anemia Humans Immunoglobulin A Immunoglobulin G Immunoglobulins Internationality Laboratories Lupus Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - diagnosis Lupus Erythematosus, Systemic - epidemiology Male Middle Aged Morbidity Patients Phenotype Phenotypes Pregnancy Registries Risk factors Smoking Systemic lupus erythematosus Thrombocytopenia Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!